Clinical trial

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

NCT01389167

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Vivitrol Normalized identity: VivitrolView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Naltrexone (oral) Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention BDRC Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Medical Management Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE3

Conditions

Opiate Dependenceverified · MONDO: opiate dependence

Interventions

VivitrolDRUG · verified · RxNorm: Vivitrol

Naltrexone (oral)DRUG

BDRCBEHAVIORAL

Medical ManagementBEHAVIORAL

Sponsors & collaborators

Yale Universitylead sponsor

St. Petersburg State Pavlov Medical Universitycollaborator

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01389167 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.